XXXX : single agent therapy for @entity281 in @entity5 @entity1 with adequate granulocyte counts.

@entity1 @entity295 @entity55 @entity5 @entity3524 @entity281 @entity325 @entity293
Seventy-eight infectious episodes in 75 @entity5 @entity1 with adequate granulocyte counts were treated with @entity3524 . Sixty-six episodes were evaluable. The overall cure rate was 77% (51/66). The response rate in 46 episodes where an organism was identified was 72% (33/46). Gram-positive and Gram-negative @entity281 responded equally with rates of 81% and 80% respectively. @entity55 , @entity295 and @entity293 occurred most frequently and had response rates of 62% (18/29), 90% (9/10) and 91% (10/11) respectively. @entity325 were associated with a poor response--40% (4/10). No serious adverse effects occurred. @entity3524 as a single agent was effective therapy for most Gram-positive and Gram-negative @entity281 in @entity5 @entity1 with adequate granulocyte counts. @entity325 and Gram-negative @entity55 might require additional agents.
